Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06427096Not ApplicableCompleted

Effect of Healthy Family Program on Population Blood Pressure

Role: lead

NCT07194785Completed

AI-Assisted Smart Stethoscope Screening for Structural Heart Disease in School Students in Ruyang County

Role: lead

NCT06455878Not ApplicableRecruiting

Mobile Applet for Weight Management in Obese Heart Failure Patients

Role: lead

NCT06764225Not ApplicableRecruiting

Effects of Low-Sodium Salt on Death, HF Hospitalization/ Emergency Department Visits and Quality of Life in HF Patients

Role: lead

NCT05238012Phase 4Completed

Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes

Role: lead

NCT04347330Not ApplicableUnknown

Cardiovascular Risk Reduction in Atrial Fibrillation Trial

Role: collaborator

NCT05333380Unknown

Study on the Effectiveness of AF Analysis Software in AF Rhythm Monitoring

Role: collaborator

NCT05006456Unknown

Real-world Experience of Catheter Ablation Using Novel Ablation Technologies for the Treatment of Atrial Fibrillation

Role: collaborator

All 8 trials loaded